Remove Books Remove Communication Remove Vaccines
article thumbnail

Barriers are limiting UK childhood vaccination, say doctors

pharmaphorum

The analysis by the Royal College of Paediatrics and Child Health suggests the main barriers to access are factors like hard-to-book and limited appointments, difficulties in attending clinics, a lack of continuity in care, and a lack of reminders for jabs.

article thumbnail

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

But together, they contribute to the ever-expanding expectation that oncology pharmacists should “know all the things,” an emotion aptly captured by Allie Brosh in her book Hyperbole and a Half. Touchstone Books; 2013. However, one person cannot do all these things well. Time Enough for Love. Putnam’s Sons; 1973.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Tips For Incoming PGY2 Pharmacy Residents

IDStewardship

For example in infectious diseases we have things like tropical medicine, travel vaccines, microbiology breakpoints, immunocompromised hosts, infection prevention, and regulatory requirements. Core resources can include society guidelines, ACCP Self Assessment Program chapters , review articles, key specialty books (e.g.,

article thumbnail

Winning Healthcare Marketing Strategy: Proven Tactics for Success

Pharma Marketing Network

Use Personalized Communication One-size-fits-all is no longer effective. For instance, reminders about flu vaccines during peak season can boost patient engagement. Chatbots, for instance, are becoming invaluable for answering patient queries or booking appointments.

HIPAA 52
article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

article thumbnail

Germany backtracks on AZ COVID vaccine age restriction

pharmaphorum

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. . France has said the vaccine can be used in people aged up to 74, rather than the entire over 65s age group. million doses unused.